Back

Intra-Cellular Therapies Stock Predictions

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Buy

ITCI
Intra-Cellular Therapies

Last Price:

84.15

Seasonality Move:

17.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 39.5% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $83.88. The Score for ITCI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 39.5% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Buy

Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

The current trend is moderately bearish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

93.45

52-Week Low:

62.78

Prediction Charts

Market Cap:

8.89B

Price in USD:

83.88

Volume:

434.44K

Beta:

1.04

Technical Analysis

SMA50:

81.61

SMA100:

78.53

SMA200:

74.07

52-Wk Change:

40.06%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 83.88 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-21	85.51	85.45	86.05	84.38
Nov-22	85.88	85.69	86.10	84.74
Nov-25	86.27	84.99	86.86	84.89
Nov-26	85.32	86.43	86.60	84.73
Nov-27	85.57	86.59	86.78	85.13
Nov-29	86.19	85.65	86.59	84.63
Dec-2	85.53	86.03	86.99	85.39
Dec-3	86.01	85.31	86.76	84.47
Dec-4	85.00	85.95	86.32	84.73
Dec-5	85.41	84.09	85.41	83.52
Dec-6	84.00	84.55	84.71	83.39
Dec-9	84.15	84.96	85.44	82.84
Dec-10	85.23	83.11	85.58	82.89
Dec-11	83.42	83.88	84.18	81.37

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.91 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.